ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
(PRUnderground) April 25th, 2019
Exosomes are currently non-reactive and FDA approved.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
..Physicians exploring exosomes as a therapeutic option should familiarize themselves with their components and signal deliveries. Components of exosomes include MSCs, cytokines, chemokines, growth factors and hyaluronic acid (HA). They are able to deliver the following signals to target cells: anti-apoptotic, anti-fibrotic, pro-angiogenic and pro-differentiation.
Adimarket, LLC is a leading distributor of products for practitioners in the regenerative medicine field. The online market offers a vast portfolio of goods, ranging from office equipment to cellular- and tissue-based products. The Global Stem Cells Group, which owns Adimarket, continually develops and launches new products specifically for regenerative medicine practitioners to assure physicians have all they need to practice in their field safely and effectively.
News 
Market Data 
Discover 
